Serum levels, and bone marrow immunohistochemical expression of, vascular endothelial growth factor in patients with chronic myeloproliferative diseases

References

• Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999;77:527–543.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669–766.
   Google Scholar
• Bellamy WT, Richter L, Frutiger Y, Grogan TM. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res 1999;59:728–733.
   PubMed Web of Science ®Google Scholar
• Dias S, Hattori K, Heissig B, Zhu Z, Wu Y, Witte L, Hicklin DJ, Tateno M, Bohlem P, Moore MS, Raffi S. Inhibition of both paracrine and autocrine VEGF/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci USA 2001;98: 10857–10862.
   PubMed Web of Science ®Google Scholar
• Bertolini F, Mancuso P, Gobbi A, Pruneri G. The thin red line: Angiogenesis in normal and malignant hematopoiesis. Exp Hematol 2000;28:99–100.
   Web of Science ®Google Scholar
• Mangi MH, Newland CA. Angiogenesis and angiogenic mediators in hematological malignancies. Br J Haematol 2000;111:43–51.
   PubMed Web of Science ®Google Scholar
• Di Raimondo F, Palumbo GA, Molica S, Giustolisi R. Angiogenesis in chronic myeloproliferative diseases. Acta Haematol 2001;106:177–183.
   PubMed Web of Science ®Google Scholar
• Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL, Dirix LY. Quantification of angiogenesis in solid human tumors: An international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996;32A:2474–2484.
   Google Scholar
• Mesa RA, Hanson CA, Rajkumar V, Schroeder G, Tefferi A. Evaluation and clinical correlations of bone marrow angiogen-esis in myelofibrosis with myeloid metaplasia. Blood 2000;96:3374–3380.
   Google Scholar
• Lundberg LG, Lerner R, Sundelin P, Rogers R, Folkman J, Palmblad J. Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity. Am J Pathol 2000;157:15–19.
   PubMed Web of Science ®Google Scholar
• Mesa RA, Hanson CA, Li C-Y, Yoon S-Y, Rajkumar SV, Schroeder G, Tefferi A. Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemia. Blood 2002; 99: 4131–4137.
   Google Scholar
• Korkolopoulou P, Viniou N, Kavantzas N, Patsouris E, Thymara I, Pavlopoulos PM, Terpos E, Stamatopoulos K, Plata E, Anargyrou K, Androulaki A, Davaris P, Yataganas X. Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: A morphometric study. Leukemia 2003;17:89–97.
   Google Scholar
• Panteli K, Zagorianakou N, Bai M, Katsaraki A, Agnantis NJ, Bourantas K:. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression. Eur J Haematol 2004; 72: 410–415.
   PubMed Web of Science ®Google Scholar
• Molica S, Vitelli G, Levato D, Gandolfo GM, Liso V. Increased serum levels of vascular endothelial growth factor predict risk of progression in early B-cell chronic lymphocytic leukemia. Br J Haematol 1999;107:605–610.
   Google Scholar
• Bertolini F, Paolucci M, Peccatori F, Cinieri S, Agazzi A, Ferrucci PF, Cocorocchio E, Goldihirsch A, Martinelli G. Angiogenic growth factors and endostatin in non-Hodgkin's lymphoma. Br J Haematol 2000;108:661–663.
   Google Scholar
• Salven P, Orpana A, Teerenhovi L, Joensuu H. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: A single-institution study of 200 patients. Blood 2000;96:3712–3718.
   PubMed Web of Science ®Google Scholar
• Molica S, Santoro R, Iuliano F, Di Raimondo F, Fichera E, Giustolisi R. Serum levels of vascular endothelial growth factor in chronic leukemias. A comparative study with emphasis on myeloproliferative disorders. Haematologica 2001;86:771.
   Google Scholar
• Di Raimondo F, Azzaro MP, Palumbo GA, Bagnato S, Stagno F, Giustolisi GM, Cassiola E, Sortino G, Guglielmo P, Giustolisi R. Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis. Leukemia 2001;15:976–980.
   PubMed Web of Science ®Google Scholar
• Musolino C, Calabro L, Bellomo G, Martello F, Loteta B, Pezzano C, Rizzo V, Alonci A. Soluble Angiogenic Factors: Implications for chronic myeloproliferative disorders. Am J Hematol 2002;69 :159–163.
   PubMed Web of Science ®Google Scholar
• Cacciola RR, Di Francesco E, Giustolisi R, Cacciola E. Elevated serum vascular endothelial growth factor levels in patients with polycythemia vera and thrombotic compli-cations. Haematologica 2000;87:774–775.
   Web of Science ®Google Scholar
• Murphy P, Ahmed N, Hassan HT. Increased serum levels of vascular endothelial growth factor correlate with splenomegaly in patients with polycythemia vera. Leuk Res 2002; 26: 1007–1010.
   Google Scholar
• Theodoridou S, Vyzantiadis T, Vakalopoulou S, Perifanis V, Tziomalos K, Vyzantiadis A, Garipidou V. Elevated levels of serum vascular endothelial growth factor in patients with polycythemia vera. Acta Haematol 2003;110:16–19.
   Google Scholar
• Liu P, Li J, Han ZC, Lu H, Wang Y, Xu B, Peng Z. Elevated plasma levels of vascular endothelial growth factor is associated with marked splenomegaly in chronic myeloid leukaemia. Leuk Lymphoma 2005;46:1761–1764.
   Google Scholar
• Chou JM, Li CY, Tefferi A. Bone marrow immunohistochem-ical studies of angiogenic cytokines and their receptors in myelofibrosis with myeloid metaplasia. Leuk Res 2003;276: 499–504.
   Google Scholar
• Wrobel T, Mazur G, Surowiak P, Wolowiec D, Jelen M, Kuliczkowsky K. Increased expression of vascular endothelial growth factor (VEGF) in bone marrow of patients with myeloproligertive disorders (MPD). Pathol Oncol Res 2003;9: 170–173.
   PubMed Web of Science ®Google Scholar
• Krauth MT, Simonitsch I, Aichberger KJ, Mayerhofer M, Sperr WR, Sillaber C, Schneeweiss B, Mann G, Gadner H, Valent P. Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease. Am J Chin Pathol 2004; 121:473–481.
   PubMed Web of Science ®Google Scholar
• Ho CL, Arora B, Hoyer JD, Wellik LE, Mesa RA, Tefferi A. Bone marrow expression of vascular endothelial growth factor in myelofibrosis with myeloid metaplasia. Eur J Haematol 2005;74:35–39.
   PubMed Web of Science ®Google Scholar
• Barosi G, Ambrosetti A, Finelli C, Grossi A, Leoni P, Liberato NL, Petti MC, Pogliani E, Ricetti M, Rupoli S, Visani G, Tura S. The Italian consensus conference on diagnostic criteria for myelofibrosis with myeloid metaplasia. Br J Haematol 1999;104:730–737.
   PubMed Web of Science ®Google Scholar
• Murphy S, Peterson P, Iland H, Laszlo J. Experience of the polycythemia vera study group with essential thrombocythe-mia: A final report on diagnostic criteria, survival and leukemic transition by treatment. Semin Hematol 1997;34:29–39.
   PubMed Web of Science ®Google Scholar
• Pearson TC. Evaluation of diagnostic criteria in polycythemia vera. Semin Haematol 2001;38:21–24.
   PubMed Web of Science ®Google Scholar
• Laurent E, Talpaz M, Kantarjian H, Kurzrock R, The PCR. gene and Philadelphia chromosome-positive leukemogenesis. Cancer Res 2001;61:2343–2355.
   Google Scholar
• Bai M, Tsanou E, Agnantis NJ, Kamina S, Grepi C, Stefanaki K, Rontogianni D, Galani V, Kanavaros P. Proliferation profile of classical Hodgkin's lymphomas. Increased expression of the protein cyclin D2 in Hodgkin's and Reed—Sternberg cells. Mod Pathol 2004;17: 1338–1345.
   PubMed Web of Science ®Google Scholar
• Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C, Selby PJ. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology. Br J Cancer 1998;77:956–964.
   Google Scholar
• Rupoli S, Da Lio L, Sisti S, Campanati G, Salvi A, Brianzoni MF, D'Amico S, Cinciripini A, Leoni P. Primary myelofi-brosis: A detailed statistical analysis of the clinicopathological variables influencing survival. Ann Hematol 1994; 68: 205–212.
   Google Scholar